scispace - formally typeset
W

William J. Murphy

Researcher at Texas A&M University

Publications -  320
Citations -  27304

William J. Murphy is an academic researcher from Texas A&M University. The author has contributed to research in topics: Genome & Immune system. The author has an hindex of 80, co-authored 293 publications receiving 25360 citations. Previous affiliations of William J. Murphy include Pontifícia Universidade Católica do Rio Grande do Sul & Texas College.

Papers
More filters
Journal ArticleDOI

CD40 Stimulation Promotes Human Secondary Immunoglobulin Responses in HuPBL-SCID Chimeras☆

TL;DR: In this article, the effects of anti-human CD40 MoAb in an in vivo system where human peripheral blood lymphocytes (huPBL) were engrafted into mice with severe combined immune deficiency (SCID), were examined for the presence of human DT-specific antibodies by ELISA.
Journal ArticleDOI

Mitochondrial DNA phylogeny of West African aplocheiloid killifishes (Cyprinodontiformes, Aplocheilidae).

TL;DR: Biogeographic inference suggests that the ancestors of this group diversified westward through upland habitat and have only relatively recently entered the lowland habitats in which Scriptaphyosemion and Callopanchax have diversified, with the latter genus reacquiring a suite of traits collectively referred to as annualism.
Journal ArticleDOI

Activated natural killer cells and interleukin-2 promote granulocytic and megakaryocytic reconstitution after syngeneic bone marrow transplantation in mice.

TL;DR: Results show that the use of populations enriched for activated NK cells after syngeneic BM transplantation (BMT) has a profound enhancing effect on engraftment primarily affecting megakaryocytic and granulocytic cell reconstitution.
Journal ArticleDOI

Constitutive expression of functional CD40 on mouse renal cancer cells: Induction of Fas and Fas-mediated killing by CD40L

TL;DR: It is reported that both mouse and human renal carcinoma cells (RCC) also constitutively express functional CD40, and this expression is demonstrated to be functionally active and may provide a molecular target for the development of new approaches to the treatment of RCC.